• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同片段长度排除了血清游离DNA的大小选择:血清和血浆样本的比较研究

Diverse fragment lengths dismiss size selection for serum cell-free DNA: a comparative study of serum and plasma samples.

作者信息

Huang Yanqin, Mu Jiayi, Qi Lina, Ge Weiting, Fang Xuefeng, Song Yongmao, Yuan Ying, Zheng Shu

机构信息

Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, P.R. China.

Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China.

出版信息

Clin Chem Lab Med. 2020 Mar 28;58(9):1451-1459. doi: 10.1515/cclm-2020-0078. Print 2020 Aug 27.

DOI:10.1515/cclm-2020-0078
PMID:32229658
Abstract

BACKGROUND

The objective of this study was to determine the features of fragment length for circulating cell-free DNA (cfDNA) from plasma and serum samples.

METHODS

Plasma and serum samples from different sources were randomly collected. Circulating cfDNA was extracted and purified by a precipitation-enriched and spin-column-based kit. The concentration of the purified DNA was immediately measured by a highly sensitive dsDNA quantitative assay, and then the fragment length was analyzed by capillary electrophoresis. The abundance of a specific fragment was estimated by the area under curve (AUC) for the fragment peak in the capillary electrophoresis.

RESULTS

A total of 199 plasma and 117 serum samples were extracted and analyzed. The average yield of cfDNA from the serum samples (131.67 ng/mL) was significantly higher than that from the plasma samples (32.78 ng/mL, p < 0.001). The average abundance of the 20-400 bp fragments in plasma cfDNA (84.4%) was significantly higher than that of serum cfDNA (51.9%, p < 0.001). Fragment peaks in serum cfDNA always presented in regions around 190 bp, 430 bp, and 630 bp, but plasma cfDNA generally showed a sharp peak in the 165-190 bp region and a much lower peak in the 300<uni-2013;400 bp region. Large fragments in plasma cfDNA were longer than 1000 bp and peaked around the 3000<uni-2013;4000 bp region while the large fragments in serum cfDNA were always shorter and peaked around the 1000 bp region.

CONCLUSIONS

The fragment lengths of serum cfDNA and plasma cfDNA have very different features. Fragment size selection is suitable for plasma cfDNA but may not apply to serum cfDNA.

摘要

背景

本研究的目的是确定来自血浆和血清样本的循环游离DNA(cfDNA)的片段长度特征。

方法

随机收集不同来源的血浆和血清样本。采用沉淀富集和基于离心柱的试剂盒提取并纯化循环cfDNA。通过高灵敏度双链DNA定量测定法立即测量纯化后DNA的浓度,然后通过毛细管电泳分析片段长度。通过毛细管电泳中片段峰的曲线下面积(AUC)估计特定片段的丰度。

结果

共提取并分析了199份血浆样本和117份血清样本。血清样本中cfDNA的平均产量(131.67 ng/mL)显著高于血浆样本(32.78 ng/mL,p < 0.001)。血浆cfDNA中20 - 400 bp片段的平均丰度(84.4%)显著高于血清cfDNA(51.9%,p < 0.001)。血清cfDNA中的片段峰总是出现在190 bp、430 bp和630 bp左右的区域,但血浆cfDNA通常在165 - 190 bp区域有一个尖锐峰,在300 - 400 bp区域有一个低得多的峰。血浆cfDNA中的大片段长度超过1000 bp,在3000 - 4000 bp区域达到峰值,而血清cfDNA中的大片段总是较短,在1000 bp区域达到峰值。

结论

血清cfDNA和血浆cfDNA的片段长度具有非常不同的特征。片段大小选择适用于血浆cfDNA,但可能不适用于血清cfDNA。

相似文献

1
Diverse fragment lengths dismiss size selection for serum cell-free DNA: a comparative study of serum and plasma samples.不同片段长度排除了血清游离DNA的大小选择:血清和血浆样本的比较研究
Clin Chem Lab Med. 2020 Mar 28;58(9):1451-1459. doi: 10.1515/cclm-2020-0078. Print 2020 Aug 27.
2
Enhanced detection of circulating tumor DNA by fragment size analysis.通过片段大小分析增强循环肿瘤 DNA 的检测。
Sci Transl Med. 2018 Nov 7;10(466). doi: 10.1126/scitranslmed.aat4921.
3
Diagnostic and Prognostic Value of Circulating DNA Fragments in Glioblastoma Multiforme Patients.多形性胶质母细胞瘤患者循环DNA片段的诊断和预后价值
Int J Mol Sci. 2024 Apr 11;25(8):4221. doi: 10.3390/ijms25084221.
4
Plasma vs. serum in circulating tumor DNA measurement: characterization by DNA fragment sizing and digital droplet polymerase chain reaction.血浆与血清中的循环肿瘤 DNA 测量:通过 DNA 片段大小分析和数字液滴聚合酶链反应进行表征。
Clin Chem Lab Med. 2020 Mar 26;58(4):527-532. doi: 10.1515/cclm-2019-0896.
5
Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma.肾细胞癌中循环肿瘤 DNA 的突变特征和碎片化的临床意义。
Cancer Sci. 2019 Feb;110(2):617-628. doi: 10.1111/cas.13906. Epub 2019 Jan 25.
6
Quantitative characterization of tumor cell-free DNA shortening.肿瘤细胞游离 DNA 缩短的定量表征。
BMC Genomics. 2020 Jul 10;21(1):473. doi: 10.1186/s12864-020-06848-9.
7
Origin of circulating free DNA in patients with lung cancer.肺癌患者循环游离 DNA 的来源。
PLoS One. 2020 Jul 7;15(7):e0235611. doi: 10.1371/journal.pone.0235611. eCollection 2020.
8
Quantification of circulating plasma cell free DNA fragments in patients with oral cancer and precancer.口腔癌及癌前病变患者循环血浆游离DNA片段的定量分析
Gulf J Oncolog. 2018 May;1(27):11-17.
9
Refined characterization of circulating tumor DNA through biological feature integration.通过生物特征整合对循环肿瘤 DNA 进行精细化表征。
Sci Rep. 2022 Feb 4;12(1):1928. doi: 10.1038/s41598-022-05606-z.
10
The clinical value of circulating free tumor DNA in testicular germ cell tumor patients.循环游离肿瘤 DNA 在睾丸生殖细胞肿瘤患者中的临床价值。
Urol Oncol. 2022 Sep;40(9):412.e15-412.e24. doi: 10.1016/j.urolonc.2022.04.021. Epub 2022 Jun 18.

引用本文的文献

1
Microbiomes of frozen blood plasma samples reveal potential pathogens in wild birds and rodents.冷冻血浆样本的微生物群落揭示了野生鸟类和啮齿动物体内的潜在病原体。
One Health. 2025 Jun 11;21:101109. doi: 10.1016/j.onehlt.2025.101109. eCollection 2025 Dec.
2
The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples.分析前变量对血液和尿液样本中游离DNA分析的影响。
Front Cell Dev Biol. 2024 May 9;12:1385041. doi: 10.3389/fcell.2024.1385041. eCollection 2024.
3
False Positives in Brucellosis Serology: Wrong Bait and Wrong Pond?
布鲁氏菌病血清学中的假阳性:诱饵错误与“池塘”错误?
Trop Med Infect Dis. 2023 May 12;8(5):274. doi: 10.3390/tropicalmed8050274.